Geode Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Sell
92,146
-450
-0.5% -$2.19K ﹤0.01% 3617
2025
Q4
$432K Buy
92,596
+680
+0.7% +$3.08K ﹤0.01% 3640
2025
Q3
$438K Sell
91,916
-23
-0% -$79 ﹤0.01% 3671
2025
Q2
$285K Buy
91,939
+864
+0.9% +$2.58K ﹤0.01% 3754
2025
Q1
$302K Buy
91,075
+100
+0.1% +$351 ﹤0.01% 3717
2024
Q4
$284K Buy
90,975
+1,500
+2% +$5.11K ﹤0.01% 3784
2024
Q3
$325K Buy
89,475
+2,624
+3% +$10.7K ﹤0.01% 3739
2024
Q2
$398K Buy
86,851
+17,688
+26% +$86.3K ﹤0.01% 3652
2024
Q1
$341K Buy
69,163
+5,460
+9% +$26.4K ﹤0.01% 3752
2023
Q4
$300K Buy
63,703
+1,207
+2% +$4.51K ﹤0.01% 3803
2023
Q3
$159K Buy
62,496
+10,056
+19% +$31.9K ﹤0.01% 4067
2023
Q2
$235K Buy
52,440
+9,474
+22% +$42.8K ﹤0.01% 3975
2023
Q1
$214K Buy
42,966
+22,285
+108% +$72.2K ﹤0.01% 4016
2022
Q4
$42K Hold
20,681
﹤0.01% 4639
2022
Q3
$54K Hold
20,681
﹤0.01% 4753
2022
Q2
$74K Hold
20,681
﹤0.01% 4682
2022
Q1
$159K Buy
20,681
+7,220
+54% +$81.1K ﹤0.01% 4482
2021
Q4
$189K Buy
+13,461
New +$198K ﹤0.01% 4501

Other funds holding SOPH

Geode Capital Management's SOPH Position: Q1 2026 in Review

Geode Capital Management reduced its SOPHiA GENETICS (SOPH) stake by 0.49% in Q1 2026, selling an estimated $2.19K and leaving 92,146 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

Geode Capital Management first reported a position in SOPH in Q4 2021 and has held it in 18 quarters since. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Geode Capital Management held 92,146 shares of SOPHiA GENETICS worth $456K as of Q1 2026.
  • Geode Capital Management sold 450 SOPHiA GENETICS shares in Q1 2026, an estimated $2.19K.
  • SOPHiA GENETICS made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3617 holding.
  • Geode Capital Management first reported a position in SOPHiA GENETICS in Q4 2021 and has held it in 18 quarters since.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.